Results 61 to 70 of about 21,386 (303)
SAGE Open Medical Case Reports, 2022 Castleman disease is a heterogeneous group of disorders of lymphoid tissue. It can often mimic other autoimmune diseases or malignancies, presenting a diagnostic dilemma to attending clinicians.
KUIS Gunathilake +4 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2021 Multicentric Castleman disease (MCD) represents a group of poorly understood lymphoproliferative disorders related to proinflammatory hypercytokinaemia.
Luís Landeiro +5 more
doaj +1 more source
Unicentric mixed variant castleman disease associated with intrabronchial plasmacytoma. [PDF]
, 2014 Castleman disease (CD), described as a heterogeneous lymphoproliferative disorder, can be divided into different subtypes according to clinical appearance (unicentric and multicentric form) and histopathological features (hyaline vascular, plasma cell ...
A Carbone +42 more
core +1 more source
Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials. [PDF]
, 2020 BACKGROUND:Siltuximab is recommended by international consensus as a first-line treatment for idiopathic multicentric Castleman disease on the basis of durable efficacy and safety data.
Casper, Corey +6 more
core
Use of Rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas [PDF]
, 2011 The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. Also autoimmune hemolytic anemia (AHA), although much more frequent in patients with chronic lymphocytic leukemia (CLL), has been described in this group of ...
Fozza, Claudio +1 more
core +4 more sources
Blood Advances, 2021 Key Points We developed a novel algorithm based on a disease-specific ICD code and diagnostic criteria to calculate incidence and prevalence of iMCD.
S. Mukherjee +4 more
semanticscholar +1 more source
HIV-associated multicentric Castleman disease [PDF]
Current Opinion in Oncology, 2011 HIV-associated multicentric Castleman disease (HIV MCD) is a rare lymphoproliferative disorder, the incidence of which appears to be increasing in the highly active antiretroviral therapy era. Current knowledge of the disease is limited and this review will discuss what is known about the pathophysiology, diagnosis, management, and prognosis of HIV MCD.
Deepa, Reddy, Ronald, Mitsuyasu
openaire +2 more sources
Unicentric Castleman Disease and Pheochromocytoma
European Journal of Case Reports in Internal Medicine, 2022 Castleman disease is an uncommon and heterogenous lymphoproliferative disorder which is classified as unicentric or multicentric depending on the number of lymph nodes involved.
Rosana Maia +4 more
doaj +1 more source
A rare case of renal thrombotic microangiopathy associated with Castleman’s disease [PDF]
, 2017 BACKGROUND: Castleman’s disease (CD) is an uncommon, heterogeneous lympho-proliferative disorder leading to high circulating levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF).
Chen, Ying Maggie +3 more
core +2 more sources
Multicentric Castleman's disease in Malawi [PDF]
The Lancet, 2014 A 51-year-old man was referred to our hospital in Lilongwe with 6 months of diffuse progressive lymphadenopathy and hepatosplenomegaly with fever, chills, night sweats, and weight loss. He had been on antiretroviral therapy for HIV for 5 years, and his CD4 cell count was 234 cells per μL and HIV RNA was 357 copies per mL.
Satish, Gopal +7 more
openaire +2 more sources